About Atanse
Atanse is a Healthcare company based in Belmont (United States) founded in 2010, and was acquired by FHC in January 2018. Neurosurgical instruments. The company was acqui-hired. Its focus areas include Life Sciences, Neurology, Medical Devices and Therapeutic Devices. Its competitors include Q’Apel Medical, Zeta Surgical and Impulse Monitoring; 3 of its 3 listed competitors have raised funding.
Company details
Atanse was founded in 2010 in Belmont, United States, as a medical device company in the neurosurgery sector. Patented radial microcannula technology is employed to allow three-dimensional dissemination of therapeutics through a single brain tissue penetration. The lead product, the Intracerebral Microinjection Instrument (IMI), is utilized by neurosurgeons for enhanced control and precision in therapeutic delivery procedures. Operations center on instrument development and innovation in brain-targeted medical solutions.
- Headquarters Belmont, United States
- Stage Acquired
- SectorsHealthcare
- Website atanse.com
- Social LinkedIn
- Acquired by FHC (Jan 2018)
Investors in Atanse
Atanse has secured backing from 1 investor. Prominent investors backing the company include FHC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Precision instruments for neurology, neurosurgery and neuroscience research | 1970 | fh-co.com | Bowdoinham, United States |
Investor details for Atanse
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Atanse
2 dated milestones of Atanse across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Atanse is founded.
- Exit Acquired by FHC.
Competitors of Atanse
Atanse has 3 listed competitors in our database, 3 of them funded. They include Q’Apel Medical, Zeta Surgical and Impulse Monitoring.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| qapelmedical.com | 2019 | Fremont, United States | $51.9M | 100 | Medical devices for neurovascular disorder treatments are provided. | |
| zetasurgical.com | 2016 | Boston, United States | $8.16M | 7 | AI-based navigation and robotics systems for surgeries are developed. | |
| impulsemonitoring.com | 2002 | Columbia, United States | $13.5M | Intraoperative neurophysiological monitoring is conducted for spinal and brain surgeries. |
Detailed competitors of Atanse
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Neurology
3 companies that operate in the same segment as Atanse (Neurology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 | |
Developer of therapeutics for psychiatric and neurologic diseases | 2002 | New York, New York, United States | USD 80.87 M | USD 250.31 M | 600 | |
Biologics platform developed for intracellular delivery in rare diseases. | 2016 | Boston, Massachusetts, United States | USD 175.25 M | USD 25.42 M | 183 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Atanse
Atanse was founded in 2010.
Atanse is headquartered in Belmont, United States. It is registered at Belmont, California, United States.
Atanse was founded in 2010 in Belmont, United States, as a medical device company in the neurosurgery sector. Patented radial microcannula technology is employed to allow three-dimensional dissemination of therapeutics through a single brain tissue penetration. The lead product, the Intracerebral Microinjection Instrument (IMI), is utilized by neurosurgeons for enhanced control and precision in therapeutic delivery procedures. Operations center on instrument development and innovation in brain-targeted medical solutions.
Atanse's top competitors include Zeta Surgical, Q’Apel Medical and Impulse Monitoring.
Atanse has 1 investor. Key investors include FHC.
Yes. Atanse was acquired by FHC in January 2018.